Arch Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ARTH Over the counter 3841 https://www.archtherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arch Therapeutics Inc

Arch Therapeutics Provides Update on Reimbursement Strategy in Additional Selling Channel - Jun 22nd, 2022 11:50 am
Arch Therapeutics’ Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC Spring - May 9th, 2022 11:50 am
Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring - Apr 13th, 2022 11:50 am
Arch Therapeutics’ AC5® Advanced Wound System to be Presented at 2022 Symposium on Advanced Wound Care (SAWC) Spring - Apr 4th, 2022 11:50 am
Arch Therapeutics Partners with Centurion Therapeutics to Expand Access to AC5® Advanced Wound System - Mar 14th, 2022 11:50 am
Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities - Jan 6th, 2022 12:50 pm
Arch Therapeutics Announces Appointment of Guy Fish to the Board - Jan 4th, 2022 2:47 pm
Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System - Dec 13th, 2021 12:50 pm
Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care Program - Dec 1st, 2021 12:50 pm
Arch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium on Advanced Wound Care (SAWC) - Nov 1st, 2021 11:50 am
Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall - Oct 25th, 2021 11:50 am
Arch Therapeutics Launches Experts in Wound Care Program - Oct 18th, 2021 11:50 am
Arch Therapeutics Provides Corporate Update - Oct 13th, 2021 8:30 pm
Arch Therapeutics to Present at the LD Micro Main Event - Oct 6th, 2021 11:50 am
Arch Therapeutics Launches Coverage and Reimbursement Pilot - Oct 4th, 2021 11:50 am
Arch Therapeutics Announces Appointment of Larry Hicks to the Board - Sep 30th, 2021 11:50 am
Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities - Sep 2nd, 2021 11:00 am
Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sales - Jul 12th, 2021 11:50 am
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021 - Jul 7th, 2021 11:50 am